Summary

Results from animal models have shown that hypertension can be regressed to normal blood pressure (BP) levels [Smallegange C et al. Hypertension 2004] and that this reduction can be maintained after pulse treatment with an angiotensin receptor blocker [Ishiguro K et al. Hypertension 2009]. The Short Treatment with Angiotensin Receptor Blocker Candesartan Surveyed by Telemedicine study [STAR CAST; Sasamura H. Hypertens Res 2008; UMIN-CTR UMIN000000941] tested the feasibility of regressing hypertension in humans.